Claudia Berenice Balderas Arroyo

Claudia Berenice Balderas Arroyo

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Food Control
Verified
Journal Article
Closed access
MAMônia Stremel Azevedo
Mônia Stremel Azevedo
SSSiluana Katia Tischer Seraglio
Siluana Katia Tischer Seraglio
GRGabriela Rocha
Gabriela Rocha
CAClaudia Berenice Balderas Arroyo
Claudia Berenice Balderas Arroyo
MPMarcel Piovezan
Marcel Piovezan
ACAna Carolina Oliveira Costa
Ana Carolina Oliveira Costa

15 July 2013 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
CAClaudia Berenice Balderas Arroyo
Claudia Berenice Balderas Arroyo
Francisco Javier RupérezFrancisco Javier Rupérez
Francisco Javier Rupérez
Elena IbáñezElena Ibáñez
Elena Ibáñez
Francisco Javier SeñoránsFrancisco Javier Señoráns
Francisco Javier Señoráns
JGJulio Guerrero‐Fernández
Julio Guerrero‐Fernández
CBCoral Barbas
Coral Barbas

1 January 2013 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
MLM.P. Lorenzo
M.P. Lorenzo
ANA. Navarrete
A. Navarrete
CAClaudia Berenice Balderas Arroyo
Claudia Berenice Balderas Arroyo
AGA. Garcia
A. Garcia

11 May 2018 in Nutrients
Verified
Journal Article
Open access
PDF file
MSMette Schmedes
Mette Schmedes
CAClaudia Berenice Balderas Arroyo
Claudia Berenice Balderas Arroyo
EAEli Kristin Aadland
Eli Kristin Aadland
HJHélène Jacques
Hélène Jacques
CLCharles Lavigne
Charles Lavigne
Hanne Christine BertramHanne Christine Bertram
Hanne Christine Bertram
The metabolic effects associated with intake of different dietary protein sources are not well characterized. We aimed to elucidate how two diets that varied in main protein sources affected the fasting and postprandial serum metabolites and lipid species. In a randomized controlled trial with crossover design, healthy adults (n = 20) underwent a 4-week intervention with two balanced diets that varied mainly in protein source (lean-seafood versus non-seafood proteins). Nuclear magnetic resonance spectroscopy and liquid chromatography-mass spectrometry analyses were applied to examine the effects of the two diets on serum metabolites. In the fasting state, the lean-seafood diet period, as opposed to the non-seafood diet period, significantly decreased the serum levels of isoleucine and valine, and during the postprandial state, a decreased level of lactate and increased levels of citrate and trimethylamine N-oxide were observed. The non-seafood diet significantly increased the fasting level of 26 lipid species including ceramides 18:1/14:0 and 18:1/23:0 and lysophosphatidylcholines 20:4 and 22:5, as compared to the lean-seafood diet. Thus, the lean-seafood diet decreased circulating isoleucine and valine levels, whereas the non-seafood diet elevated the levels of certain ceramides, metabolites that are associated with insulin-resistance.

11 December 2017 in Diabetes
Verified
Journal Article
Closed access
LALotta E. Andersson
Lotta E. Andersson
LSLiliya Shcherbina
Liliya Shcherbina
MAMahmoud Al-Majdoub
Mahmoud Al-Majdoub
NVNeelanjan Vishnu
Neelanjan Vishnu
CAClaudia Berenice Balderas Arroyo
Claudia Berenice Balderas Arroyo
Peter SpégelPeter Spégel
Peter Spégel
Glucagon-like peptide-1 (GLP-1), secreted from intestinal L-cells, glucose-dependently stimulates insulin secretion from beta-cells. This glucose-dependence prevents hypoglycemia, rendering GLP-1 analogues a useful and safe treatment modality in type-2 diabetes. While the amino acid glutamine is a potent elicitor of GLP-1 secretion, the responsible mechanism remains unclear. We investigated how GLP-1 secretion is metabolically coupled in L-cells (GLUTag) and in vivo in mice, using the insulin-secreting cell-line INS-1 832/13 as reference. A membrane-permeable glutamate analogue (dimethylglutamate; DMG), acting down-stream of electrogenic transporters, elicited similar alterations in metabolism as glutamine in both cell-lines. Both DMG and glutamine alone elicited GLP-1 secretion in GLUTag cells and in vivo, whereas activation of glutamate dehydrogenase (GDH) was required to stimulate insulin secretion from INS-1 832/13 cells. Pharmacological inhibition in vivo of GDH blocked secretion of GLP-1 in response to DMG. In conclusion, our results suggest that non-electrogenic nutrient uptake and metabolism play an important role in L-cell stimulus secretion coupling. Metabolism of glutamine and related analogues by GDH in the L-cell may explain why GLP-1 secretion, but not that of insulin, is activated by these secretagogues in vivo.

1 December 2010 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
CAClaudia Berenice Balderas Arroyo
Claudia Berenice Balderas Arroyo
ALMA VILLASEÑORALMA VILLASEÑOR
ALMA VILLASEÑOR
AGAntonia García
Antonia García
Francisco Javier RupérezFrancisco Javier Rupérez
Francisco Javier Rupérez
Elena IbáñezElena Ibáñez
Elena Ibáñez
CBCoral Barbas
Coral Barbas